Search for monoglyceride lipase inhibitors: Synthesis and screening of arylthioamides derivatives

Medicinal Chemistry Research

Volumn 18, Issue 4, 2009, Pages 243-254

  Kapanda, Coco N ^a   Muccioli, Giulio G ^a   Labar, Geoffray ^a   Draoui, Nihed ^a   Lambert, Didier M ^a   Poupaert, Jacques H ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

2 Arachidonoylglycerol; Arylthioamides derivatives; Monoglyceride lipase; Monoglyceride lipase inhibitors

Indexed keywords

2 BIPHENYL 4 YL 1 MORPHOLIN 4 YL ETHANETHION; 2 BIPHENYL 4 YL N PHENETHYL THIOACETAMIDE; 2 CHLORO N PHENETHYL THIOBENZAMIDE; 2 CHLORO PHENYLMORPHOLIN 4 YL METHANETHIONE; 2,4 DICHLORO N PHENETHYL THIOBENZAMIDE; 3 NITRO PHENYLMORPHOLIN 4 YL METHANETHIONE; 3,4 DICHLORO N PHENETHYL THIOBENZAMIDE; 4 CYCLOHEXYL PHENYLMORPHOLIN 4 YL METHANETHIONE; 4 PHENETHYLTHIOCARBAMOYL BENZOIC ACID METHYL ESTER; ACYLGLYCEROL LIPASE INHIBITOR; FATTY ACID AMIDASE; FATTY ACID AMIDASE INHIBITOR; THIOAMIDE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG ACTIVITY; DRUG HYDROLYSIS; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; INFRARED SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 67349267347     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-008-9123-2     Document Type: Article

References (33)

1. BF Cravatt DK Giang SP Mayfield DL Boger RA Lerner NB Gilula 1996 Molecular Characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature 384 83 87 10.1038/384083a0
2. WA Devane L Hanus A Breuer RG Pertwee LA Stevenson G Griffin 1992 Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1946 1949 10.1126/science.1470919
3. V Di Marzo A Fontana H Cadas S Schinelli G Cimino JC Schwartz 1994 Formation and inactivation of endogenous cannabinoid anandamide in central neurons Nature 372 686 691 10.1038/372686a0
4. TP Dinh D Carpenter FM Leslie TF Freund I Katona SL Sensi 2002 Brain monoglyceride lipase participating in endocannabinoid inactivation Proc Natl Acad Sci USA 99 10819 10824 10.1073/pnas.152334899
5. DG Deutsch R Omeir G Arreaza 1997 Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase Biochem Pharmacol 53 255 260 10.1016/S0006-2952(96)00830-1
6. L Facci R Dal Toso S Romanello A Buriani SD Skaper A Leon 1995 Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide Proc Natl Acad Sci USA 92 3376 3380 10.1073/pnas.92.8.3376
7. S Galiegue S Mary J Marchand D Dussossoy D Carriere P Carayon 1995 Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations Eur J Biochem 232 54 61 10.1111/j.1432-1033.1995.tb20780.x
8. Y Hashimotodani T Ohno-Shosaku M Kano 2007 Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabiboid signalling in hippocampus J Neurosci 27 5 1211 1219 10.1523/JNEUROSCI.4159-06.2007
9. CJ Hillard WS Edgemont A Jarrahian WB Campbell 1997 Accumulation of N- arachidonoylethanolamide (anandamide) into cerebellar granule cells occurs via facilitated diffusion J Neurochem 69 631 638
10. EJ Ishac L Jiang KD Lake K Varga ME Abood G Kunos 1996 Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves Br J Pharmacol 118 20213 22028
11. A Jayamanne R Greenwood VA Mitchell S Aslan D Piomelli CW Vaughan 2006 Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models Br J Pharmacol 147 3 281 288 10.1038/sj.bjp.0706510
12. DG Kathuria S Gaetani D Flegey 2003 Modulation of anxiety through blockade of anandamide hydrolysis Nat Med 9 76 81 10.1038/nm803
13. S Kishimoto Y Kobayashi S Oka M Gokoh K Waku T Sugiura 2004 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells J Biochem 135 4 517 524 10.1093/jb/mvh063
14. G Labar C Michaux 2007 Fatty acid amide hydrolase: from characterization to Therapeutics Chem Biodivers 4 1882 1902 10.1002/cbdv.200790157
15. G Labar C Bauvois GG Muccioli J Wouters DM Lambert 2007 Disulfiram is an inhibitor of purified monoacylglycerollipase, the enzyme regulating 2-arachidonoylglycerol signalling ChemBioChem 8 1293 1297 10.1002/cbic.200700139
16. G Labar FV Vliet J Wouters DM Lambert 2008 A MBP-FAAH fusion protein as a tool to produce human and rat fatty acid amide hydrolase: expression and pharmacological comparison Amino Acids 34 127 133 10.1007/s00726-007-0540-1
17. DM Lambert CJ Fowler 2005 The endocannabinoid system: drugs targets, lead compounds, and potential therapeutic applications J Med Chem 48 16 5059 5087 10.1021/jm058183t
18. JK Makara M Mor D Flegey 2005 Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signalling in hippocampus Nat Neurosci 8 1139 1141 10.1038/nn1521
19. R Mechoulam 1995 Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem Pharmacol 50 83 90 10.1016/0006-2952(95)00109-D
20. SA Moore GG Nomikos AK Dickason-Chesterfield DA Schober JM Schaus XUY-C Ying B-P L Phebus RMA Simmons D Li S Iyengar CC Felder 2005 Identification of a high-affinity binding site involved in the transport of endocannabinoids Proc Natl Acad Sci USA 102 17852 17857 10.1073/pnas.0507470102
21. GG Muccioli C Xu E Odah E Cudaback JA Cisneros DM Lambert 2007 Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells J Neurosci 27 2883 2889 10.1523/JNEUROSCI.4830-06.2007
22. P Pacher S Bátkai G Kunos 2006 The endocannabinoid system as an emerging target of pharmacotherapy Pharmacol Rev 58 389 462 10.1124/pr.58.3.2
23. JH Poupaert S Duarte E Colacino P Depreux CR McCurdy DM Lambert 2004 Willgerodt-Kindler microwave-enhanced synthesis of thioamides derivatives Phos Sulf Sil Rel. Elem 179 1959 1973
24. 10 Lett Org Chem 2 330 333 10.2174/1570178054038957
25. A Rolfs J Liebscher 1998 3-morpholino-2-phenylthioacrylic acid morpholide and 5-(4-bromobenzoyl-2-(4-morpholino)-3-phenylthiophene Org Synth Coll 9 99
26. SM Saario JT Laitinen 2007 Monoglyceride lipase as an enzyme hydrolyzing 2-arachidonoylglycerol Chem Biodivers 4 8 1903 1913 10.1002/cbdv.200790158
27. SM Saario OM Salo T Nevalainen A Poso JT Laitinen T Järvinen 2005 Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysisi of 2-arachidonoyl-glycerol in rat cerebellar membranes Chem Biol 12 649 656 10.1016/j.chembiol.2005.04.013
28. SM Saario A Poso RO Juvonen T Järvinen OM Salo-Ahen 2006 Fatty Acid Amid Hydrolase inhibitors from virtual screening of the endocannabinoid system J Med Chem 49 4650 4656 10.1021/jm060394q
29. S Sagan L Vanance Y Torrens J Cordier J Glowinski C Giaume 1999 Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes Eur J Neurosci 11 691 699 10.1046/j.1460-9568.1999.00480.x
30. T Sugiura S Kondo A Sukagawa S Nakane A Shinoda K Itoh 1995 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brainBiochem Biophys Res Commun 215 89 905 10.1006/bbrc.1995.2437
31. G Tarzia F Antonietti A Duranti A Tontini M Mor S Rivara P Traldi G Astarita A King JR Clapper D Piomelli 2007 Identification of a bioactive impurity in a commercial sample of 6-methyl-2-p-tolylaminobenzo[d][1,3] oxazin-4-one (URB754) Ann di Chim 97 887 894
32. S Vandevoorde KO Jonsson G Labar E Persson DM Lambert CJ Fowler 2007 Lack of selectivity of URB602 for 2-oleoylglycerol compared to Anandamide hydrolysis in vitro Br J Pharmacol 150 186 191 10.1038/sj.bjp.0706971
33. RI Wilson RA Nicoll 2001 Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses Nature 410 588 592 10.1038/35069076